Prescription Pattern of Risperidone and Olanzapine for Elderly Psychiatric Inpatients in a Naturalistic Setting
Journal of Korean Geriatric Psychiatry
; : 40-43, 2007.
Article
em Ko
| WPRIM
| ID: wpr-121565
Biblioteca responsável:
WPRO
ABSTRACT
Several studies have reported that either risperidone or olanzapine is effective and tolerable in the elderly patients with psychotic symptoms. However, there is a lack of clinical data of risperidone and olanzapine prescription for elderly patients in the Aisan population. We reviewed retrospectively the medical records of risperidone (n=112) and olanzapine (n=96) treated patients older than age 60 who were admitted to a university-affiliated hospital between October 2005 and August 2006. The mean daily dose of risperidone was 3.4+/-1.5 mg and olanzapine, 8.8+/-5.6 mg, respectively. The response rate on the CGI (much and very much improved) appeared to be 67.4% in the risperidone group and 70.8% in the olanzapine group, respectively. Adverse events were reported in 48.2% in the risperidone group and 46.9% in the olanzapine group, without serious adverse events, respectively. This study showed that either risperidone or olanzapine would be effective and tolerable in elderly patients with psychotic symptoms and that provides similar results to those reported from western countries.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Transtornos Psicóticos
/
Prontuários Médicos
/
Estudos Retrospectivos
/
Risperidona
/
Prescrições
/
Pacientes Internados
Tipo de estudo:
Observational_studies
Limite:
Aged
/
Humans
Idioma:
Ko
Revista:
Journal of Korean Geriatric Psychiatry
Ano de publicação:
2007
Tipo de documento:
Article